Related Experiment Video
Updated: May 10, 2026

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
Interaction between Paracoccidioides brasiliensis conidia and the coagulation system: involvement of fibrinogen
Diana Tamayo1, Orville Hernández, Cesar Muñoz-Cadavid
1Molecular and Cell Biology Unit, Corporación para Investigaciones Biológicas, Medellín, Colombia.
Abstract:
The infectious process starts with an initial contact between pathogen and host. We have previously demonstrated that Paracoccidioides brasiliensis conidia interact with plasma proteins including fibrinogen, which is considered the major component of the coagulation system. In this study, we evaluated the in vitro capacity of P. brasiliensis conidia to aggregate with plasma proteins and compounds involved in the coagulation system. We assessed the aggregation of P. brasiliensis conidia after incubation with human serum or plasma in the presence or absence of anticoagulants, extracellular matrix (ECM) proteins, metabolic and protein inhibitors, monosaccharides and other compounds. Additionally, prothrombin and partial thromboplastin times were determined after the interaction of P. brasiliensis conidia with human plasma. ECM proteins, monosaccharides and human plasma significantly induced P. brasiliensis conidial aggregation; however, anticoagulants and metabolic and protein inhibitors diminished the aggregation process. The extrinsic coagulation pathway was not affected by the interaction between P. brasiliensis conidia and plasma proteins, while the intrinsic pathway was markedly altered. These results indicate that P. brasiliensis conidia interact with proteins involved in the coagulation system. This interaction may play an important role in the initial inflammatory response, as well as fungal disease progression caused by P. brasiliensis dissemination.
Insights
Paracoccidioides brasiliensis conidia aggregate with human plasma proteins, influencing blood coagulation. This interaction may impact the initial inflammatory response and fungal disease progression.
Area of Science:
- Mycology
- Immunology
- Hematology
Background:
- The infectious process begins with pathogen-host contact.
- Paracoccidioides brasiliensis conidia interact with plasma proteins like fibrinogen.
- Fibrinogen is a key component of the blood coagulation system.
Purpose of the Study:
- To evaluate the in vitro aggregation of P. brasiliensis conidia with plasma proteins and coagulation factors.
- To assess the impact of various compounds on this aggregation process.
- To determine the effect of conidial interaction on blood coagulation pathways.
Main Methods:
- Incubation of P. brasiliensis conidia with human serum or plasma.
- Testing aggregation with extracellular matrix (ECM) proteins, monosaccharides, anticoagulants, and inhibitors.
- Measurement of prothrombin time and partial thromboplastin time.
- Assessing alterations in coagulation pathways (extrinsic and intrinsic).
Main Results:
- Extracellular matrix proteins, monosaccharides, and human plasma significantly induced conidial aggregation.
- Anticoagulants and metabolic/protein inhibitors reduced conidial aggregation.
- The extrinsic coagulation pathway remained unaffected, while the intrinsic pathway was significantly altered.
Conclusions:
- P. brasiliensis conidia interact with proteins of the blood coagulation system.
- This interaction influences the intrinsic coagulation pathway.
- The findings suggest a role for coagulation protein interaction in the initial inflammatory response and fungal disease dissemination.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Complement System
Clot Retraction and Fibrinolysis
